A Digital Therapeutic (CT-152) as Adjunct To Antidepressant Medication: A Phase 3 Randomized Controlled Trial (the Mirai study) - Psychiatric Times

Submitted by Anonymous (not verified) on Mon, 02/09/2026 - 14:14

A Digital Therapeutic (CT-152) as Adjunct To Antidepressant Medication: A Phase 3 Randomized Controlled Trial (the Mirai study)  Psychiatric Times